Serum Separation Gel Market Growth, Size, Trends Analysis and Future Opportunities

Serum Separation Gel Market Growth, Size, Trends Analysis - By Product, By End User - Regional Outlook, Competitive Strategies and Segment Forecast to 2034

Q: How can I get a sample report on the Serum Separation Gel Market?

You can get the sample pages by clicking the link - Click Here

Published: May-2025	Report ID: HLCA25143	Pages: 1 - 250	Formats^*:
Category : Healthcare

Serum Separation Gel Market Introduction and Overview

According to SPER Market Research, the Global Serum Separation Gel Market is estimated to reach USD 16.05 billion by 2034 with a CAGR of 7.16%.

The report includes an in-depth analysis of the Global Serum Separation Gel Market, including market size and trends, product mix, Applications, and supplier analysis. The serum separation gel market is anticipated to develop at a compound annual growth rate (CAGR) of 7.16% during the forecast period, from its estimated USD 8.04 billion in 2024. This could be as a result of the growing popularity of serum separation gels and their versatility in a wide range of medical situations. For a variety of reasons, including the faster and more complete separation of serum and blood clot, hospitals, clinics, blood banks, biotechnological firms, research and academic institutions, and others, acquire serum separation gels.

By Product Insights:

Serum separation gel with integrated tubes and serum separation gel without are the two product-based market categories. Serum separation gel with integrated tubes held the largest market share in 2024. This is due to the fact that these tubes are increasingly being used in clinical studies to treat infectious diseases. Improved convenience and sample handling may be the reason for the increased demand. The segment's expansion is also expected to be driven by advantages including enhanced radiation resistance and reduced interference with test results.

By End User Insights:

The market for serum separation gel is segmented into many end-user groups, such as blood banks, hospitals, and pharmaceutical companies. In 2024, the blood bank sector had the biggest market share. The increasing usage of blood and its componentsâ€”platelets, red blood cells (RBC), white blood cells (WBC), and plasmaâ€”in medicine may be connected to this. Serum separation gel is essential in this situation to separate the different components of blood.

Regional Insights:

North America led the market in 2024. One of the primary reasons for this region's domination is a significant increase in the number of instances of infectious diseases and haematological disorders. Due to significant comorbidities and poor immune systems, the older group accounted for the majority of reported cases. Furthermore, additional blood banks with cutting-edge infrastructure and easily accessible co-pay programs contribute to market expansion. Over the course of the projected period, Asia-Pacific is anticipated to have the fastest CAGR. This is because more and more blood banks are being established in countries like China, Japan, South Korea, India, Thailand, Australia, and Singapore.

Get more information on this report: Download Free Sample PDF

Market Competitive Landscape:

Major players in the Serum Separation Gel Market are continuously developing new products to meet customer needs. They focus on research and development to improve product efficiency and accuracy. Key drivers of market growth include the rising demand for accurate diagnostic tests, awareness of early disease detection, and technological advancements. Thermo Fisher Scientific is a leading company, offering a wide range of high-quality serum separation gels tailored for various applications, recognized for their accuracy and reliability.

Recent Developments:

In May 2023, Greiner AG launched the VACUETTE CAT Serum Fast Separator Tube, a new blood collection technology. This product reduces erythrocytes during centrifugation by combining the speed of a plasma tube with premium serum. This innovation highlights Greiner AG's dedication to improving efficiency and accuracy in diagnostics for healthcare professionals and patients.

Scope of the report:

Report Metric	Details
Market size available for years	2021-2034
Base year considered	2024
Forecast period	2025-2034
Segments covered	By Product, By End User
Regions covered	North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa
Companies Covered	Becton, Dickinson and Company, BIOSIGMA S.p.A, Bio-Rad Laboratories, Inc, Cardinal Health, Inc, Danaher Corporation, FL MEDICAL s.r.l, Greiner AG, InterVacTechnology, Qiagen N.V, Sekisui Chemical CO., LTD.

Key Topics Covered in the Report:

Global Serum Separation Gel Market Size (FYâ€™2021-FYâ€™2034)
Overview of Global Serum Separation Gel Market
Segmentation of Global Serum Separation Gel Market By Product (Serum Separation Gel Without Integrated Tubes, Serum Separation Gel with Integrated Tubes)
Segmentation of Global Serum Separation Gel Market By End-User (Hospitals, Blood Banks, Pharmaceutical Companies)
Statistical Snap of Global Serum Separation Gel Market
Expansion Analysis of Global Serum Separation Gel Market
Problems and Obstacles in Global Serum Separation Gel Market
Competitive Landscape in the Global Serum Separation Gel Market
Details on Current Investment in Global Serum Separation Gel Market
Competitive Analysis of Global Serum Separation Gel Market
Prominent Players in the Global Serum Separation Gel Market
SWOT Analysis of Global Serum Separation Gel Market
Global Serum Separation Gel Market Future Outlook and Projections (FYâ€™2025-FYâ€™2034)
Recommendations from Analyst

1. Introduction

1.1. Scope of the report
1.2. Market segment analysis

2. Research Methodology

2.1. Research data source

2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPERâ€™s internal database
2.1.4. Premium insight from KOLâ€™s

2.2. Market size estimation

2.2.1. Top-down and Bottom-up approach

2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

4.1. Driver, Restraint, Opportunity and Challenges analysis

4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges

5. Market variable and outlook

5.1. SWOT Analysis

5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats

5.2. PESTEL Analysis

5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4. Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape

5.3. PORTERâ€™s Five Forces

5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry

5.4. Heat Map Analysis

6. Competitive Landscape

6.1. Global Serum Separation Gel Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Serum Separation Gel Market

7. Global Serum Separation Gel Market, By Product (USD Million) 2021-2034

7.1. Serum separation gel without integrated tubes
7.2. Serum separation gel with integrated tubes

8. Global Serum Separation Gel Market, By End-User (USD Million) 2021-2034

8.1. Hospitals
8.2. Blood banks
8.3. Pharmaceutical companies
8.4. Other end-users

9. Global Serum Separation Gel Market, (USD Million) 2021-2034

9.1. Global Serum Separation Gel Market Size and Market Share

10. Global Serum Separation Gel Market, By Region, (USD Million) 2021-2034

10.1. Asia-Pacific

10.1.1. Australia
10.1.2. China
10.1.3. India
10.1.4. Japan
10.1.5. South Korea
10.1.6. Rest of Asia-Pacific

10.2. Europe

10.2.1. France
10.2.2. Germany
10.2.3. Italy
10.2.4. Spain
10.2.5. United Kingdom
10.2.6. Rest of Europe

10.3. Middle East and Africa

10.3.1. Kingdom of Saudi Arabia
10.3.2. United Arab Emirates
10.3.3. Qatar
10.3.4. South Africa
10.3.5. Egypt
10.3.6. Morocco
10.3.7. Nigeria
10.3.8. Rest of Middle-East and Africa

10.4. North America

10.4.1. Canada
10.4.2. Mexico
10.4.3. United States

10.5. Latin America

10.5.1. Argentina
10.5.2. Brazil
10.5.3. Rest of Latin America

11. Company Profile

11.1. Becton, Dickinson and Company

11.1.1. Company details
11.1.2. Financial outlook
11.1.3. Product summary
11.1.4. Recent developments

11.2. BIOSIGMA S.p.A

11.2.1. Company details
11.2.2. Financial outlook
11.2.3. Product summary
11.2.4. Recent developments

11.3. Bio-Rad Laboratories, Inc

11.3.1. Company details
11.3.2. Financial outlook
11.3.3. Product summary
11.3.4. Recent developments

11.4. Cardinal Health, Inc.

11.4.1. Company details
11.4.2. Financial outlook
11.4.3. Product summary
11.4.4. Recent developments

11.5. Danaher Corporation

11.5.1. Company details
11.5.2. Financial outlook
11.5.3. Product summary
11.5.4. Recent developments

11.6. FL MEDICAL s.r.l

11.6.1. Company details
11.6.2. Financial outlook
11.6.3. Product summary
11.6.4. Recent developments

11.7. Greiner AG

11.7.1. Company details
11.7.2. Financial outlook
11.7.3. Product summary
11.7.4. Recent developments

11.8. Inter Vac Technology

11.8.1. Company details
11.8.2. Financial outlook
11.8.3. Product summary
11.8.4. Recent developments

11.9. Qiagen N.V

11.9.1. Company details
11.9.2. Financial outlook
11.9.3. Product summary
11.9.4. Recent developments

11.10. Sekisui Chemical CO., LTD

11.10.1. Company details
11.10.2. Financial outlook
11.10.3. Product summary
11.10.4. Recent developments

11.11. Others

12. Conclusion

13. List of Abbreviations

14. Reference Links

SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.

The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.

SPER-Methodology-1

SPER-Methodology-2

SPER-Methodology-3

Frequently Asked Questions About This Report

How big is the Serum Separation Gel Market?

Serum Separation Gel Market is projected to reach USD 16.05 billion by 2034, growing at a CAGR of of 7.16% during the forecast period.

What is the growth rate of the Serum Separation Gel Market?

Serum Separation Gel Market grew in Market size from 2025. The Market is expected to reach USD 16.05 billion by 2034, at a CAGR of 7.16% during the forecast period.

What is the anticipated CAGR of the Serum Separation Gel Market?

Serum Separation Gel Market CAGR of 7.16% during the forecast period.

How can I get a sample report on the Serum Separation Gel Market?

You can get the sample pages by clicking the link - Click Here

What is the Market size of the Serum Separation Gel Market?

Serum Separation Gel Market size is USD 16.05 billion from 2025 to 2034.

Which segment is expected to Serum Separation Gel Market?

Serum Separation Gel Market is covered By Product, By End User

Which region is expected to have the highest Market share in the Serum Separation Gel Market?

The North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa is the highest Market share in the Serum Separation Gel Market .

Who are the key players in Serum Separation Gel Market?

Becton, Dickinson and Company, BIOSIGMA S.p.A, Bio-Rad Laboratories, Inc, Cardinal Health, Inc, Danaher Corporation, FL MEDICAL s.r.l, Greiner AG, InterVacTechnology, Qiagen N.V, Sekisui Chemical CO., LTD.

What is the conclusion of the Serum Separation Gel Market?

The report includes an in-depth analysis of the Global Serum Separation Gel Market, including market size and trends, product mix, Applications, and supplier analysis.